BHP Faces Major Port Hedland Strike as Labor Talks Stall Ahead of Production Report 
TSMC Q2 Revenue Surges 36% as AI Chip Demand Powers Growth Ahead of Earnings 
DeepSeek Eyes China IPO as AI Startup Seeks $71 Billion Valuation in New Funding Round 
Stripe, Advent Offer $53 Billion Deal to Acquire PayPal: Reuters 
Arm Stock Falls After HSBC Downgrade, Citing Limited Near-Term AI Upside 
DBS Targets S$1 Trillion Wealth AUM by 2030 Amid Asia Wealth Boom 
Alibaba Stock Jumps as China Approves Apple Intelligence Powered by Qwen AI 
SK Hynix Shares Drop After Strong Nasdaq Debut Despite $26 Billion ADR Listing 
Deutsche Bank Fined A$2 Million by ASIC Over OTC Derivatives Reporting Errors 
Taiwan Mangoes Head to Europe as Premium Fruit Exports Expand 
SoftBank Corp Partners With Sierra to Expand AI Customer Support Across Japan 
Australia Flags Child Safety Gaps at Apple, Meta, Google Over Online Sexual Extortion 
Richemont Q1 Sales Beat Forecast as Cartier Demand Drives Strong Growth 
Genesis Minerals to Acquire Vault in A$5.6 Billion Deal After Regis Withdraws 
Muji Owner Ryohin Keikaku Stock Soars After Raising Full-Year Earnings Forecast 
Apple Intelligence Cleared for China as Alibaba and Baidu AI Power iPhone Features 
Nippon Paint Reportedly Offers Up to €7.5 Billion for Akzo Nobel Decorative Paints Business 
Dublin, Jan. 13, 2016 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/5mpv9n/hemoglobin_a1c) has announced the addition of the "Hemoglobin A1c Testing Markets" report to their offering.
Hemoglobin A1c (HbA1c) testing is the most recent major technology to have entered the diabetes testing market. As the global prevalence of diabetes mellitus continues to increase rapidly, with more than 366 million diabetics worldwide, hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued market growth. This report describes the specific market segment that encompasses hemoglobin A1c testing for diagnosing and monitoring diabetes.
The study reviews all of the generally accepted clinical analytical methods that are currently in use today for measuring HbA1c levels. Moreover, it examines clinical measurement devices and reagents as utilized in hospitals, clinics, doctor's offices and at-home care locations. The report also analyzes almost all of the companies known to be marketing, manufacturing or developing hemoglobin A1c testing. Detailed tables and charts with sales forecasts and market-share data are also included.
Companies Mentioned
- Abbott Laboratories
- A. Menarini Diagnostics
- Alere, Inc.
- ARKRAY USA, Inc.
- Axis-Shield Plc
- Bayer Healthcare Diagnostics
- Beckman Coulter, Inc
- Bio-Rad Laboratories, Inc.
- EKF Diagnostics
- Infopia Co., Ltd.
- Ortho Clinical Diagnostics (part of Johnson & Johnson)
- Quotient Diagnostics
- Randox Laboratories
- Roche Diagnostics
- Siemens AG
- Tosoh Bioscience, Inc.
- Trinity Biotech Plc
Key Topics Covered:
1. Overview
2. Diabetes
3. Market Analysis: Size, Growth, Share and Competitors
4. Overview of HbA1c Testing
5. HbA1c Testing Devices on the Market
6. Business Trends in HbA1c Testing
7. Regulatory Environment and Insurance Reimbursements
8. Company Profiles
For more information visit http://www.researchandmarkets.com/research/5mpv9n/hemoglobin_a1c
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Coagulation and Hemostasis Testing
